Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Virology Journal
Published in: Virology Journal 1/2023

Open Access 01-12-2023 | Hepatitis B | Research

The effect of hepatitis B virus on the risk of pregnancy outcomes: a systematic review and meta-analysis of cohort studies

Authors: Maryam Afraie, Ghobad Moradi, Kamran Zamani, Mobin Azami, Yousef Moradi

Published in: Virology Journal | Issue 1/2023

Login to get access

Abstract

Background

The effect of HBV on neonatal and maternal outcomes can create a basis for more accurate clinical decision-making. So, the aim of this meta-analysis is to detrmine the effect of chronic hepatitis B virus on the risk of pregnancy outcomes by combining cohort studies.

Methods

International databases in this meta-analysis included the Cumulated Index to Nursing and Allied Health Literature (CINAHL), SPORT Discuss via the EBSCO interface, PubMed (Medline), Scopus, Web of Science, Embase, which were searched up to April 2023. All cohort studies reporting the risk ratio (RR) with a 95% confidence interval (CI) were included in the study. The quality assessment was done based on the Newcastle–Ottawa Scale (NOS).

Results

Finally, thirty-five cohort studies were selected for meta-analysis. Outcomes of interest included pre-eclampsia, gestational diabetes, abortion, preterm birth, infant death, and other related outcomes. Results showed that the pooled RR for incident gestational diabetes in pregnant women with choronic hepatitis B infection was 1.16 (RR: 1.16; 95% CI 1.13–1.18; I-square: 92.89%; P value: 0.00). Similarly, the association between the presence of hepatitis B infection in pregnant women and the occurrence of pre-eclampsia was 1.10 (RR: 1.10; 95% CI 1.04–1.16; I-square: 92.06%; P value: 0.00). The risk of preterm delivery in pregnant women with hepatitis B infection was 1.17 times that of pregnant women without hepatitis B infection (RR: 1.17; 95% CI 1.14–1.20; I-squared: 94.32%; P value: 0.00).

Conclusion

This meta-analysis found that hepatitis B infection during pregnancy may be associated with an increased risk of gestational diabetes, preterm delivery, pre-eclampsia, and eclampsia. However, confirmation of this association, as well as the specific biological pathways involved in the association between HBV infection and pregnancy outcomes, requires further investigation.
Appendix
Available only for authorised users
Literature
1.
Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell. 1982;29(2):403–15.PubMed
2.
Kao J-H. Role of viral factors in the natural course and therapy of chronic hepatitis B. Hep Intl. 2007;1:415–30.
3.
4.
Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212–9.PubMed
5.
Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis. 2004;11(2):97–107.
6.
7.
Liaw Y-F, Chu C-M. Hepatitis B virus infection. The lancet. 2009;373(9663):582–92.
8.
Nguyen MH, Wong G, Gane E, Kao J-H, Dusheiko G. Hepatitis B virus: advances in prevention, diagnosis, and therapy. Clin Microbiol Rev. 2020;33(2):e00046-e119.PubMedPubMedCentral
9.
Pan CQ, Duan ZP, Bhamidimarri KR, Zou HB, Liang XF, Li JIE, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol. 2012;10(5):452–9.PubMed
10.
Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int. 2009;29:133–9.PubMed
11.
Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, et al. CD8+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol. 2003;77(1):68–76.PubMedPubMedCentral
12.
Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci. 1990;87(17):6599–603.PubMedPubMedCentral
13.
Trehanpati N, Hissar S, Shrivastav S, Sarin SK. Immunological mechanisms of hepatitis B virus persistence in newborns. Indian J Med Res. 2013;138(5):700.PubMedPubMedCentral
14.
Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case–control study. J Hepatol. 2005;43(5):771–5.PubMed
15.
Pavel A, Tîrşia E, Maior E, Cristea A. Detrimental effects of hepatitis B virus infection on the development of the product of conception. Virologie. 1983;34(1):35–40.PubMed
16.
Hak SD, Do YS, Kyun RL. The influence of hepatitis B virus on the fetus in pregnancy. Pediatr Int. 1987;29(3):449–54.
17.
Su WH, Wang PH, Yuan CC, Chang SP. Fetal meconium peritonitis in the infant of a woman with fulminant hepatitis B. A case report. J Reprod Med. 2002;47(11):952–4.PubMed
18.
Lao TT, Chan BCP, Leung W-C, Ho L-F, Tse K-Y. Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatol. 2007;47(1):46–50.PubMed
19.
Sirilert S, Tongsong T. Hepatitis B virus infection in pregnancy: immunological response, natural course and pregnancy outcomes. J Clin Med. 2021;10(13):2926.PubMedPubMedCentral
20.
Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Cranio-Maxillofac Surg. 2011;39(2):91–2.
21.
Stokkeland K, Ludvigsson JF, Hultcrantz R, Ekbom A, Höijer J, Bottai M, et al. Pregnancy outcome in more than 5000 births to women with viral hepatitis: a population-based cohort study in Sweden. Eur J Epidemiol. 2017;32(7):617–25.PubMedPubMedCentral
22.
Tan J, Liu X, Mao X, Yu J, Chen M, Li Y, et al. HBsAg positivity during pregnancy and adverse maternal outcomes: a retrospective cohort analysis. J Viral Hepat. 2016;23(10):812–9.PubMed
23.
Bajema KL, Stankiewicz Karita HC, Tenforde MW, Hawes SE, Heffron R. Maternal hepatitis B infection and pregnancy outcomes in the United States: a population-based cohort study. Open Forum Infectious Diseases. 2018;5(6)
24.
Bierhoff M, Angkurawaranon C, Myat Min A, Gilder ME, Win Tun N, Keereevijitt A, et al. Maternal hepatitis B infection burden, comorbidity and pregnancy outcome in a low-income population on the Myanmar-Thailand border: a retrospective cohort study. J Pregnancy. 2019;2019:8435019.PubMedPubMedCentral
25.
Chen B, Wang Y, Lange M, Kushner T. Hepatitis C is associated with more adverse pregnancy outcomes than hepatitis B: A 7-year national inpatient sample study. Hepatol Commun. 2022;6(9):2465–73.PubMedPubMedCentral
26.
Chen Y, Ning W, Wang X, Chen Y, Wu B, Tao J. Maternal hepatitis B surface antigen carrier status and pregnancy outcome: a retrospective cohort study. Epidemiol Infect. 2022;150:1–22.PubMed
27.
Connell LE, Salihu HM, Salemi JL, August EM, Weldeselasse H, Mbah AK. Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes. Liver Int. 2011;31(8):1163–70.PubMed
28.
Lao TT, Sahota DS, Cheng YK, Law LW, Leung TY. Maternal hepatitis B surface antigen status and incidence of pre-eclampsia. J Viral Hepat. 2013;20(5):343–9.PubMed
29.
Lok WY, Kong CW, To WWK. Prevalence of Hepatitis B Carrier Status and Its Negative Association with Hypertensive Disorders in Pregnancy. Obstetr Gynecol Int. 2021;2021.
30.
Mak SL, Leung KY. Hepatitis B carriers in Hong Kong: prevalence and pregnancy outcomes. HKJGOM. 2013;13(1):67–73.
31.
Reddick KL, Jhaveri R, Gandhi M, James AH, Swamy GK. Pregnancy outcomes associated with viral hepatitis. J Viral Hepat. 2011;18(7):e394–8.PubMed
32.
Sirilert S, Traisrisilp K, Sirivatanapa P, Tongsong T. Pregnancy outcomes among chronic carriers of hepatitis B virus. Int J Gynaecol Obstet. 2014;126(2):106–10.PubMed
33.
Sun Q, Lao TT, Du M, Xie M, Sun Y, Bai B, et al. Chronic maternal hepatitis B virus infection and pregnancy outcome- a single center study in Kunming, China. BMC Infect Dis. 2021;21(1):253.PubMedPubMedCentral
34.
To WW, Cheung W, Mok KM. Hepatitis B surface antigen carrier status and its correlation to gestational hypertension. Aust N Z J Obstet Gynaecol. 2003;43(2):119–22.PubMed
35.
Wu K, Wang H, Li S, Zhang H, Zhu B. Maternal hepatitis B infection status and adverse pregnancy outcomes: a retrospective cohort analysis. Arch Gynecol Obstet. 2020;302(3):595–602.PubMed
36.
Xiong Y, Liu C, Huang S, Wang J, Qi Y, Yao G, et al. Impact of maternal infection with hepatitis B virus on pregnancy complications and neonatal outcomes for women undergoing assisted reproductive technology treatment: A population-based study. J Viral Hepat. 2021;28(4):613–20.PubMed
37.
Yin W, Chen B, Yang Y, Li X, Li R, Xie J, et al. Association between maternal hepatitis B virus carrier and gestational diabetes mellitus: a retrospective cohort analysis. Virol J. 2021;18(1):226.PubMedPubMedCentral
38.
Zhang Y, Chen J, Liao T, Chen S, Yan J, Lin X. Maternal HBsAg carriers and pregnancy outcomes: a retrospective cohort analysis of 85,190 pregnancies. BMC Pregnancy Childbirth. 2020;20(1)
39.
Zhao M, Yang S, Su X, Hung TC, Liu Y, Zheng W. Hepatitis B virus infection and increased risk of gestational diabetes regardless of liver function status: a xiamen area population-based Study. Front Physiol. 2022;13: 938149.PubMedPubMedCentral
40.
Zhuang X, Cui AM, Wang Q, Cheng XY, Shen Y, Cai WH, et al. Liver Dysfunction during pregnancy and Its association of with preterm birth in China: a prospective cohort study. EBioMedicine. 2017;26:152–6.PubMedPubMedCentral
41.
Cheung KW, Wang WL, So PL, Wong DN, Mak ASL, Hui WN, et al. Original relationship between viral load and pregnancy outcomes among hepatitis B carriers. Taiwan J Obstet Gynecol. 2022;61(4):630–3.PubMed
42.
Cui AM, Cheng XY, Shao JG, Li HB, Wang XL, Shen Y, et al. Maternal hepatitis B virus carrier status and pregnancy outcomes: a prospective cohort study. BMC Pregnancy Childbirth. 2016;16:87.PubMedPubMedCentral
43.
Tan J, Huang S, He G, Tang L, Ren Y, Zheng J, et al. Maternal hepatitis B surface antigen carrier status and its impact on neonatal outcomes: a cohort study of 21 947 singleton newborns in China. J Matern Fetal Neonatal Med. 2017;30(18):2219–24.PubMed
44.
Thungsuk R. Maternal hepatitis B infection and pregnacy outcomes. J Prapokklao Hospital Clin Med Educ Center. 2008;25(3):246–54.
45.
Wang L, Li L, Huang C, Diao L, Lian R, Li Y, et al. Maternal chronic hepatitis B virus infection does not affect pregnancy outcomes in infertile patients receiving first in vitro fertilization treatment. Fertil Steril. 2019;112(2):250-7.e1.PubMed
46.
Zhao Y, Chen YL, Song HQ, Huang PY, Wang LY, Liu W, et al. Effects of maternal hepatitis B surface antigen positive status on the pregnancy outcomes: a retrospective study in Xiamen, China, 2011–2018. PLoS ONE. 2020;15(3): e0229732.PubMedPubMedCentral
47.
Peng S, Wan Z, Lin X, Li X, Du Y. Maternal hepatitis B surface antigen carrier status increased the incidence of gestational diabetes mellitus. BMC Infect Dis. 2019;19(1):147.PubMedPubMedCentral
48.
Zheng S, Zhang H, Chen R, Yan J, Han Q. Pregnancy complicated with hepatitis B virus infection and preterm birth: a retrospective cohort study. BMC Pregnancy Childbirth. 2021;21(1):513.PubMedPubMedCentral
49.
Huang X, Tan H, Li X, Zhou S, Wen SW, Luo M. Maternal chronic HBV infection would not increase the risk of pregnancy-induced hypertension–results from pregnancy cohort in Liuyang rural China. PLoS ONE. 2014;9(12): e114248.PubMedPubMedCentral
50.
Lobstein S, Faber R, Tillmann HL. Prevalence of hepatitis B among pregnant women and its impact on pregnancy and newborn complications at a tertiary hospital in the eastern part of Germany. Digestion. 2011;83(1–2):76–82.PubMed
51.
Chen J, Zhang S, Zhou YH, Xu BY, Hu YL. Minimal adverse influence of maternal hepatitis B carrier status on perinatal outcomes and child’s growth. J Maternal-Fetal Neonatal Med. 2015;28(18):2192–6.
52.
Liu J, Zhang SK, Liu M, Wang QM, Shen HP, Zhang YP. Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study. Lancet Global Health. 2017;5(6):E624–32.PubMed
53.
Salemi JL, Whiteman VE, August EM, Chandler K, Mbah AK, Salihu HM. Maternal hepatitis B and hepatitis C infection and neonatal neurological outcomes. J Viral Hepat. 2014;21(11):e144–53.PubMed
54.
Xu C, Bao Y, Zuo J, Li Y, Tang Y, Qu X, et al. Maternal chronic hepatitis B virus infection and the risk of preterm birth: A retrospective cohort analysis in Chinese women. J Viral Hepat. 2021;28(10):1422–30.PubMed
55.
Ahmed MA, Sharif ME, Rayis DA, Nasr AM, Adam I. Hepatitis B infection and preeclampsia among pregnant Sudanese women. Virology journal. 2018;15:1–4.
56.
Huang QT, Chen JH, Zhong M, Hang LL, Wei SS, Yu YH. Chronic hepatitis b infection is associated with decreased risk of preeclampsia: a meta-analysis of observational studies. Cell Physiol Biochem. 2016;38(5):1860–8.PubMed
57.
Huang QT, Wei SS, Zhong M, Hang LL, Xu YY, Cai GX, et al. Chronic hepatitis B infection and risk of preterm labor: a meta-analysis of observational studies. J Clin Virol. 2014;61(1):3–8.PubMed
58.
Ishizaka N, Ishizaka Y, Takahashi E, Toda EI, Hashimoto H, Ohno M, et al. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation. 2002;105(9):1028–30.PubMed
59.
Jiang R, Wang T, Yao Y, Zhou F, Huang X. Hepatitis B infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. Medicine. 2020;99(31).
60.
Ma X, Sun D, Li C, Ying J, Yan Y. Chronic hepatitis B virus infection and preterm labor(birth) in pregnant women-an updated systematic review and meta-analysis. J Med Virol. 2018;90(1):93–100.PubMed
61.
Asaye Z, Aferu T, Asefa A, Feyissa D, Regasa T, Kebede O, et al. Prevalence of hepatitis b virus among pregnant women on antenatal care follow-up at mizan-tepi university teaching hospital and mizan health center southwest ethiopia. Int J General Med. 2021;195–200.
62.
Carpio GCA, Taguba AQ, Tan LCQ, Ong JP, Daez MLO. Prevalence and risk factors of hepatitis B infection in pregnant women at the prenatal clinic of the university of the Philippines-Philippine general hospital. Clin Gastroenterol Hepatol. 2015;13(7): e83.
63.
Hirokoshi K, Maeshima Y, Kobayashi K, Matsuura E, Sugiyama H, Yamasaki Y, et al. Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia. Am J Hypertens. 2005;18(9):1181–8.PubMed
64.
Khakhkhar VM, Bhuva PJ, Bhuva SP, Patel CP, Cholera MS. Sero-prevalence of hepatitis B amongst pregnant women attending the antenatal clinic of a tertiary care hospital, Jamnagar (Gujarat). Natl J Med Res. 2012;2(03):362–5.
65.
Yakasai IA, Ayyuba Ru, Abubakar IS, Ibrahim SA. Sero-prevalence of hepatitis B virus infection and its risk factors among pregnant women attending antenatal clinic at Aminu Kano Teaching Hospital, Kano, Nigeria. J Basic Clin Reprod Sci. 2012;1(1–2):49–55.
66.
Chien C-H, Chen L-W, Lin C-L, Chang S-W, Shyu Y-C, Chen K-F, et al. Unawareness of hepatitis B virus infection confers on higher rate of metabolic syndrome: a community-based study. Sci Rep. 2017;7(1):9869.PubMedPubMedCentral
67.
Joo EJ, Chang Y, Yeom JS, Lee YG, Ryu S. Hepatitis B infection is associated with an increased incidence of thrombocytopenia in healthy adults without cirrhosis. J Viral Hepatitis. 2017;24(3):253–8.
68.
Shah AS, Amarapurkar DN. Spectrum of hepatitis B and renal involvement. Liver Int. 2018;38(1):23–32.PubMed
69.
Chen DS. Public health measures to control hepatitis B virus infection in the developing countries of the Asia-Pacific region. J Gastroenterol Hepatol. 2000;15:E7–10.PubMed
70.
Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol. 2000;15:E3–6.PubMed
71.
Ma J, Bauman A. Obstetric profiles and pregnancy outcomes of immigrant women in New South Wales, 1990–1992. Aust N Z J Obstet Gynaecol. 1996;36(2):119–25.PubMed
72.
Kawsar M, Goh B. Hepatitis B virus infection among Chinese residents in the United Kingdom. Sexually transmitted infections. 2002;78(3):166–8.PubMedPubMedCentral
73.
Chen YL, Peng L, He J, Wu JX, Tian RX, Xu JQ, et al. Impact of hepatitis B virus infection on maternal and infant outcomes of women with gestational diabetes mellitus: a three-year retrospective study. J Diabetes Compl. 2022;36(6).
74.
Kong D, Liu H, Wei S, Wang Y, Hu A, Han W, et al. A meta-analysis of the association between gestational diabetes mellitus and chronic hepatitis B infection during pregnancy. BMC Res Notes. 2014;7:139.PubMedPubMedCentral
75.
Beischer NA, Oats JN, Henry OA, Sheedy MT, Walstab JE. Incidence and severity of gestational diabetes mellitus according to country of birth in women living in Australia. Diabetes. 1991;40(Supplement_2):35–8.PubMed
76.
Yue D, Molyneaux L, Ross G, Constantino M, Child A, Turtle J. Why does ethnicity affect prevalence of gestational diabetes? The underwater volcano theory. Diabet Med. 1996;13(8):748–52.PubMed
77.
Keramat A, Younesian M, Fesharaki MG, Hasani M, Mirzaei S, Ebrahimi E, et al. Inactive hepatitis B carrier and pregnancy outcomes: a systematic review and meta–analysis. Iran J Public Health. 2017;46(4):468.PubMedPubMedCentral
78.
Oliveira D, Pereira F, do Rosário Martins M, Castro R, Cordeiro L, Fronteira I. A systematic review of the maternal and neonatal complications in hepatitis B infection. J Clin Virol. 2020;133:104680.PubMed
Metadata
Title
The effect of hepatitis B virus on the risk of pregnancy outcomes: a systematic review and meta-analysis of cohort studies
Authors
Maryam Afraie
Ghobad Moradi
Kamran Zamani
Mobin Azami
Yousef Moradi
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2023
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-023-02182-0

Other articles of this Issue 1/2023

Virology Journal 1/2023 Go to the issue

Research

ARIH1 inhibits influenza A virus replication and facilitates RIG-I dependent immune signaling by interacting with SQSTM1/p62

Review

The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics

Review

Epstein-Barr virus infection: the micro and macro worlds

Research

Comparative phylogenetic analysis and transcriptomic profiling of Dengue (DENV-3 genotype I) outbreak in 2021 in Bangladesh

Review

The mechanisms of nerve injury caused by viral infection in the occurrence of gastrointestinal motility disorder-related diseases

Research

Host sex disparity and viral genotype dependence of the glycosylation level of small Hepatitis B surface protein in patients with HBeAg-positive chronic Hepatitis B
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits